Presently, there are 2 options for the replacement of the temporomandibular joint for end-stage pathology: autogenous bone grafting or alloplastic joint replacement. This article presents evidence-based advantages and disadvantages for each of these management options to assist both surgeons and their patients in making that choice.
Keywords: Alloplastic temporomandibular replacement; Autogenous bone graft; Costochondral graft; Temporomandibular joint replacement.
Copyright © 2018 Elsevier Inc. All rights reserved.